Aachen, Germany

Stefan Schunk

This inventor holds 36 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 19 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Gruenenthal Gmbh, Grunenthal Gmbh. Active years: 2011-2024.

USPTO Granted Patents = 36 

% Patents Active = 19.4

 

 

Average Co-Inventor Count = 6.8

ph-index = 6

Forward Citations = 104(Granted Patents)


Company Filing History:


Years Active: 2011-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Triazolo Quinoxaline
Sulfonamide Compounds
Pyrrole Carboxamides
Indole Derivatives
Bradykinin Receptor
Spirocyclic Compounds
Heteroaryl Derivatives
Aryl Compounds
Tetrahydropyranylsulfones
Pyrimidine Compounds
Disulfonamide Compounds
36 patents (USPTO):Explore Patents

Title: The Innovative Mind of Stefan Schunk

Introduction: Stefan Schunk is a visionary inventor based in Aachen, Germany, known for his groundbreaking contributions to the field of technology and engineering.

Latest Patents: Stefan Schunk holds several patents in the areas of renewable energy, sustainable transportation, and advanced manufacturing processes, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a background in mechanical engineering and a passion for innovation, Stefan Schunk has led numerous projects that have revolutionized industries, earning him recognition as a pioneer in his field.

Collaborations: Throughout his career, Stefan Schunk has collaborated with leading research institutions, universities, and companies to bring his ideas to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Stefan Schunk's dedication to pushing the boundaries of technology and his relentless pursuit of innovation continue to inspire the next generation of inventors and engineers worldwide.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…